# METHYLERGONOVINE MALEATE
> **ANDA212233** · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2020-05-01
## Drug
- **FDA Application Number:** ANDA212233
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHYLERGONOVINE MALEATE
- **Generic name:** METHYLERGONOVINE MALEATE
- **Active ingredients:** METHYLERGONOVINE MALEATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TP ANDA HOLDINGS
- **Manufacturer:** Volley Pharmaceuticals, LLC
- **First approval:** 2020-05-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212233)
---
*MORVS · CC0 1.0*